documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
8 rows where docket_id = "FDA-1995-D-0288" and posted_year = 2021 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: open_for_comment, last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1995-D-0288-0051 | FDA | Changes to be Reported for Product and Establishment License Application; Guidance FDA-1995-D-0288 | Ref. 7 - Q12 Technical and Regulatory Considerations for Pharmaceutical Producte Lyfecycle Managment Annex May 2021 RE Chemistry, Manufacturing, and Controls Changes to an Approved Application: Certain Biological Products; Guidance for Industry | Supporting & Related Material | Background Material | 2021-07-07T04:00:00Z | 2021 | 7 | 2021-07-07T12:23:19Z | 0 | 0 | 0900006484bd4b2d | |||
| FDA-1995-D-0288-0053 | FDA | Changes to be Reported for Product and Establishment License Application; Guidance FDA-1995-D-0288 | Ref. 9 - Comparability Protocols for Human Drugs and Biologics April 2016 RE Chemistry, Manufacturing, and Controls Changes to an Approved Application: Certain Biological Products; Guidance for Industry | Supporting & Related Material | Background Material | 2021-07-07T04:00:00Z | 2021 | 7 | 2021-07-07T12:23:31Z | 0 | 0 | 0900006484bd4b2f | |||
| FDA-1995-D-0288-0054 | FDA | Changes to be Reported for Product and Establishment License Application; Guidance FDA-1995-D-0288 | Ref. 15 - Good Review Managment Principles and Practice for New Drug Applications and Biologics License Sept 2018 RE Chemistry, Manufacturing, and Controls Changes to an Approved Application: Certain Biological Products; Guidance for Industry | Supporting & Related Material | Background Material | 2021-07-07T04:00:00Z | 2021 | 7 | 2021-07-07T12:23:37Z | 0 | 0 | 0900006484bd4b30 | |||
| FDA-1995-D-0288-0052 | FDA | Changes to be Reported for Product and Establishment License Application; Guidance FDA-1995-D-0288 | Ref. 7 - ICH Q 12 Annex RE Chemistry, Manufacturing, and Controls Changes to an Approved Application: Certain Biological Products; Guidance for Industry | Supporting & Related Material | Background Material | 2021-07-07T04:00:00Z | 2021 | 7 | 2021-07-07T12:23:25Z | 0 | 0 | 0900006484bd4b2e | |||
| FDA-1995-D-0288-0055 | FDA | Changes to be Reported for Product and Establishment License Application; Guidance FDA-1995-D-0288 | Ref. 23 - Standards Development and the Use of Standards in Regulatory Submissions Reviewed in the Center for Biologics Evaluation and Research March 2019 RE Chemistry, Manufacturing, and Controls Changes to an Approved Application: Certain Biological Products; Guidance for Industry | Supporting & Related Material | Background Material | 2021-07-07T04:00:00Z | 2021 | 7 | 2021-07-07T12:23:44Z | 0 | 0 | 0900006484bd4b31 | |||
| FDA-1995-D-0288-0050 | FDA | Changes to be Reported for Product and Establishment License Application; Guidance FDA-1995-D-0288 | PAC FINAL GUIDANCE reference list RE Chemistry, Manufacturing, and Controls Changes to an Approved Application: Certain Biological Products; Guidance for Industry | Supporting & Related Material | Background Material | 2021-07-07T04:00:00Z | 2021 | 7 | 2021-07-07T12:23:11Z | 0 | 0 | 0900006484bcd0c7 | |||
| FDA-1995-D-0288-0049 | FDA | Changes to be Reported for Product and Establishment License Application; Guidance FDA-1995-D-0288 | Chemistry, Manufacturing, and Controls Changes to an Approved Application: Certain Biological Products; Guidance for Industry | Other | Guidance | 2021-06-24T04:00:00Z | 2021 | 6 | 2021-06-24T04:00:00Z | 2024-11-12T23:32:40Z | 1 | 0 | 0900006484baa9ff | ||
| FDA-1995-D-0288-0048 | FDA | Changes to be Reported for Product and Establishment License Application; Guidance FDA-1995-D-0288 | Chemistry, Manufacturing, and Controls Changes to an Approved Application: Certain Biological Products; Guidance for Industry; Availability | Notice | Notice of Availability | 2021-06-24T04:00:00Z | 2021 | 6 | 2021-06-24T04:00:00Z | 2021-06-24T14:02:39Z | 2021-13392 | 0 | 0 | 0900006484ba948e |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);